Bicycle Therapeutics plc (BCYC) Return on equity 2019–2025
Bicycle Therapeutics plc (BCYC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-35.9%FY2025 · since FY2019: -32.8% → -35.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -35.9% | -14.6 pp |
| FY2024 | -21.3% | +27.4 pp |
| FY2023 | -48.7% | -7.1 pp |
| FY2022 | -41.6% | -22.3 pp |
| FY2021 | -19.3% | +34.1 pp |
| FY2020 | -53.4% | -20.6 pp |
| FY2019 | -32.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice